Toxoplasma gondii serine-protease inhibitor-1: A new adjuvant candidate for asthma therapy.

PLoS One · 2017 · PMC5658115 · PMID 29073215

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Although not statistically significant, animals treated with rTgPI-1 alone showed a trend to diminished IgE antibodies.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.